Palmitoylethanolamide (PEA) Inhibits SARS-CoV-2 Entry by Interacting with S Protein and ACE-2 Receptor
팔미토일에탄올아미드(PEA)는 S 단백질 및 ACE-2 수용체와 상호작용하여 SARS-CoV-2 진입을 억제합니다
Article
[키워드] ACE-2
activate
activated
adjuvant therapy
Antiviral
antiviral agent
antiviral drug
antiviral drugs
antiviral potency
binding
bioactive lipids
cascade
cause
cellular
clinical test
Clinical tests
clinical trial
connection
Coronaviruses
counteract
Course
COVID-19
COVID-19 pandemic
Degradation
derangement
Disruption
drop
droplets
energy
entry receptor
event
Evidence
fatty
Fatty acid
generate
glycoprotein
Glycoproteins
highlight
Huh-7 cells
humans
in viral
Infection
Inflammation
inflammatory stimuli
lack
life cycle
Lipid
lipid droplets
lipid metabolism
lipids
mechanism of action
mechanisms
membrane
metabolism
nutraceutical
palmitoylethanolamide
Pathways
PEA
Prevent
protective effect
Protective effects
recent
replicate
Replication
Research
RNA virus
S protein
SARS-CoV-2
SARS-CoV-2 entry
SARS-CoV-2 S protein
second
significantly
Spike protein
the SARS-CoV-2
therapy
Toxicity
transcription factor
Treatment
Usage
viral infection
viral life cycle
virus
viruses
VSV
[DOI] 10.3390/v14051080 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/v14051080 PMC 바로가기 [Article Type] Article